MRI of Benign Female Pelvis Fiona M
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Metabolomics for Diagnosis and Prognosis of Uterine Diseases? a Systematic Review
Journal of Personalized Medicine Review Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review Janina Tokarz 1 , Jerzy Adamski 1,2,3,4 and Tea Lanišnik Rižner 5,* 1 Research Unit Molecular Endocrinology and Metabolism, Helmholtz Zentrum München, German Research Centre for Environmental Health, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; [email protected] (J.T.); [email protected] (J.A.) 2 German Centre for Diabetes Research, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany 3 Lehrstuhl für Experimentelle Genetik, Technische Universität München, Freising-Weihenstephan, 85764 Neuherberg, Germany 4 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore 5 Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia * Correspondence: [email protected]; Tel.: + 386-1-5437657 Received: 4 November 2020; Accepted: 18 December 2020; Published: 21 December 2020 Abstract: This systematic review analyses the contribution of metabolomics to the identification of diagnostic and prognostic biomarkers for uterine diseases. These diseases are diagnosed invasively, which entails delayed treatment and a worse clinical outcome. New options for diagnosis and prognosis are needed. PubMed, OVID, and Scopus were searched for research papers on metabolomics in physiological fluids and tissues from patients with uterine diseases. The search identified 484 records. Based on inclusion and exclusion criteria, 44 studies were included into the review. Relevant data were extracted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) checklist and quality was assessed using the QUADOMICS tool. The selected metabolomics studies analysed plasma, serum, urine, peritoneal, endometrial, and cervico-vaginal fluid, ectopic/eutopic endometrium, and cervical tissue. -
A Rare Presentation of Benign Brenner Tumor of Ovary: a Case Report
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Periasamy S et al. Int J Reprod Contracept Obstet Gynecol. 2018 Jul;7(7):2971-2974 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20182920 Case Report A rare presentation of benign Brenner tumor of ovary: a case report Sumathi Periasamy1, Subha Sivagami Sengodan2*, Devipriya1, Anbarasi Pandian2 1Department of Surgery, 2Department of Obstetrics and Gynaecology, Government Mohan Kumaramangalam Medical College, Salem, Tamil Nadu, India Received: 17 April 2018 Accepted: 23 May 2018 *Correspondence: Dr. Subha Sivagami Sengodan, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Brenner tumors are rare ovarian tumors accounting for 2-3% of all ovarian neoplasms and about 2% of these tumors are borderline (proliferating) or malignant. These tumors are commonly seen in 4th-8th decades of life with a peak in late 40s and early 50s. Benign Brenner tumors are usually small, <2cm in diameter and often detected incidentally during surgery or on pathological examination. Authors report a case of a large, calcified benign Brenner tumor in a 55-year-old postmenopausal woman who presented with complaint of abdominal pain and mass in abdomen. Imaging revealed large complex solid cystic pelvic mass -peritoneal fibrosarcoma. She underwent laparotomy which revealed huge Brenner tumor weighing 9kg arising from left uterine cornual end extending up to epigastric region. -
Immunohistochemical and Electron Microscopic Findings in Benign Fibroepithelial Vaginal Polyps J Clin Pathol: First Published As 10.1136/Jcp.43.3.224 on 1 March 1990
224 J Clin Pathol 1990;43:224-229 Immunohistochemical and electron microscopic findings in benign fibroepithelial vaginal polyps J Clin Pathol: first published as 10.1136/jcp.43.3.224 on 1 March 1990. Downloaded from T P Rollason, P Byrne, A Williams Abstract LIGHT MICROSCOPY Eleven classic benign "fibroepithelial Sections were cut from routinely processed, polyps" of the vagina were examined paraffin wax embedded blocks at 4 gm and using a panel of immunocytochemical immunocytochemical techniques were agents. Two were also examined electron performed using a standard peroxidase- microscopically. In all cases the stellate antiperoxidase method.7 The antibodies used and multinucleate stromal cells were as follows: polyclonal rabbit characteristic of these lesions stained antimyoglobin (batch A324, Dako Ltd, High strongly for desmin, indicating muscle Wycombe, Buckinghamshire), monoclonal intermediate filament production. In anti-desmin (batch M724, Dako Ltd), mono- common with uterine fibroleiomyomata, clonal anti-epithelial membrane antigen (batch numerous mast cells were also often M613, Dako Ltd), monoclonal anti-vimentin seen. Myoglobin staining was negative. (batch M725, Dako Ltd), polyclonal rabbit Electron microscopical examination anti-cytokeratin (Bio-nuclear services, Read- confirmed that the stromal cells con- ing) and monoclonal anti cytokeratin NCL tained abundant thin filaments with focal 5D3 (batch M503, Bio-nuclear services). densities and also showed the ultrastruc- Mast cells were shown by a standard tural features usually associated with chloroacetate esterase method using pararo- myofibroblasts. saniline,8 which gave an intense red cyto- It is concluded that these tumours plasmic colouration, and by the routine would be better designated polypoid toluidine blue method. myofibroblastomas in view of the above An attempt was made to assess semiquan- findings. -
Fibro-Epithelial Polyp: Case Report with Literature Review
ISSN: 2456-8090 (online) CASE REPORT International Healthcare Research Journal 2017;1(7):14-17. DOI: 10.26440/IHRJ/01_07/116 QR CODE Fibro-Epithelial Polyp: Case Report with Literature Review RATNA SAMUDRAWAR 1, HEENA MAZHAR2, MUKESH KUMAR KASHYAP3, RUBI GUPTA4 A Oral fibroma is the most common benign soft tissue tumor caused due to continuous trauma from sharp cusp of teeth or faulty dental B restoration. It presents as sessile or occasionally pedunculated painless swelling which can be soft to firm in consistency. Its incidence occurs mostly during third to fifth decade and shows preference for female. Its occurrence corresponds with intraoral areas that are S prone to trauma such as the tongue, buccal mucosa and labial mucosa, lip, gingiva. Even with conservative surgical excision, the T lesion may recur until the source of continuous irritation persists. This article presents a case of large size oral fibroma on left alveolar R region associated with ulceration along with literature review. A C KEYWORDS: Benign Connective Tissue Tumor, Fibro-epithelial Polyp, Irritation Fibroma, Traumatic Fibroma, Focal Fibrous T Hyperplasia. K INTRODUCTION Fibroma of the oral mucosa is the most common complaint of growth in left lower back region of benign soft tissue tumor of the oral cavity derived the mouth since 4 months. History elicited that from fibrous connective tissues (CTs).1 Its the a solitary, painless growth had been observed pathogenesis lies in the fact that due to continues in his left mandibular molar region which was local trauma, a type of reactive hyperplasia of initially small in size and then it gradually fibrous tissue occurs.2 Thus, “Focal fibrous enlarged to present size of oval shape, well- hyperplasia” (FFH) term was suggested by Daley defined, pedunculated lesion. -
ISUOG Basic Training Examining the Uterus, Cervix, Ovaries and Adnexae: Abnormal Findings
ISUOG Basic Training Examining the Uterus, Cervix, Ovaries and Adnexae: Abnormal Findings Douglas Dumbrill, South Africa EditableBasic training text here Learning objective At the end of the lecture you will be able to: • compare the differences between typical normal and common abnormal appearances presenting in gynecological ultrasound examinations EditableBasic training text here Key questions • How do the ultrasound appearances of fibroids and adenomyosis differ? • What are the typical ultrasound appearances of the most common endometrial and intracavitary pathologies? • What are the typical ultrasound appearances of the most common pathologies in the adnexae? • How do I describe my ultrasound findings using the standardized IOTA and IETA terminology? • Which patients should I refer for specialist opinion? EditableBasic training text here The basis for ultrasound diagnosis in gynecology • Gray scale ultrasound • To use Doppler ultrasound, you must – be familiar with Doppler physics – understand the pitfalls of Doppler ultrasound – recognize Doppler artefacts • Doppler settings must be correct – Pulse repetition frequency (PRF) 0.3- 0.6 KHz EditableBasic training text here Common myometrial pathology • Myoma • Adenomyosis EditableBasic training text here Most common myometrial pathology - myoma Round, oval or lobulated solid tumor casting stripy shadows EditableBasic training text here Hyperechogenic uterine myoma EditableBasic training text here Cystically degenerated myomas EditableBasic training text here Typical myoma Round, oval -
Soft Tissue Sarcoma Classifications
Soft Tissue Sarcoma Classifications Contents: 1. Introduction 2. Summary of SSCRG’s decisions 3. Issue by issue summary of discussions A: List of codes to be included as Soft Tissue Sarcomas B: Full list of codes discussed with decisions C: Sarcomas of neither bone nor soft tissue D: Classifications by other organisations 1. Introduction We live in an age when it is increasingly important to have ‘key facts’ and ‘headline messages’. The national registry for bone and soft tissue sarcoma want to be able to produce high level factsheets for the general public with statements such as ‘There are 2000 soft tissue sarcomas annually in England’ or ‘Survival for soft tissue sarcomas is (eg) 75%’ It is not possible to write factsheets and data briefings like this, without a shared understanding from the SSCRG about which sarcomas we wish to include in our headline statistics. The registry accepts that soft tissue sarcomas are a very complex and heterogeneous group of cancers which do not easily reduce to headline figures. We will still strive to collect all data from cancer registries about anything that is ‘like a sarcoma’. We will also produce focussed data briefings on sites such as dermatofibrosarcomas and Kaposi’s sarcomas – the aim is not to forget any sites we exclude! The majority of soft tissue sarcomas have proved fairly uncontroversial in discussions with individual members of the SSCRG, but there were 7 particular issues it was necessary to make a group decision on. This paper records the decisions made and the rationale behind these decisions. 2. Summary of SSCRG’s decisions: Include all tumours with morphology codes as listed in Appendix A for any cancer site except C40 and C41 (bone). -
American Family Physician Web Site At
Diagnosis and Management of Adnexal Masses VANESSA GIVENS, MD; GREGG MITCHELL, MD; CAROLYN HARRAWAY-SMITH, MD; AVINASH REDDY, MD; and DAVID L. MANESS, DO, MSS, University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee Adnexal masses represent a spectrum of conditions from gynecologic and nongynecologic sources. They may be benign or malignant. The initial detection and evaluation of an adnexal mass requires a high index of suspicion, a thorough history and physical examination, and careful attention to subtle historical clues. Timely, appropriate labo- ratory and radiographic studies are required. The most common symptoms reported by women with ovarian cancer are pelvic or abdominal pain; increased abdominal size; bloating; urinary urgency, frequency, or incontinence; early satiety; difficulty eating; and weight loss. These vague symptoms are present for months in up to 93 percent of patients with ovarian cancer. Any of these symptoms occurring daily for more than two weeks, or with failure to respond to appropriate therapy warrant further evaluation. Transvaginal ultrasonography remains the standard for evaluation of adnexal masses. Findings suggestive of malignancy in an adnexal mass include a solid component, thick septations (greater than 2 to 3 mm), bilaterality, Doppler flow to the solid component of the mass, and presence of ascites. Fam- ily physicians can manage many nonmalignant adnexal masses; however, prepubescent girls and postmenopausal women with an adnexal mass should be referred to a gynecologist or gynecologic oncologist for further treatment. All women, regardless of menopausal status, should be referred if they have evidence of metastatic disease, ascites, a complex mass, an adnexal mass greater than 10 cm, or any mass that persists longer than 12 weeks. -
Tumors of the Uterus and Ovaries
CALIFORNIA TUMOR TISSUE REGISTRY 104th SEMI-ANNUAL CANCER SEMINAR ON TUMORS OF THE UTERUS AND OVARIES CASE HISTORIES PRELECTOR: Fattaneh A. Tavassoll, M.D. Chairperson, GYN and Breast Pathology Armed Forces Institute of Pathology Washington, D.C. June 7, 1998 Westin South Coast Plaza Costa Mesa, California CHAIRMAN: Mark Janssen, M.D. Professor of Pathology Kaiser Pennanente Medical Center Anaheim, California CASE HISTORIES 104ru SEMI-ANNUAL SEMINAR CASE #t- ACC. 2S232 A 48-year-old, gravida 3, P.ilra 3, female on oral contraceptives presented with dysmenorrhea and amenorrhea of three months duration. Initial treatment included Provera and oral contraceptives. Pelvic ultrasound lev~aled a 7 x 5 em right ovarian cyst and a possible small uterine fibroid. Six months later, she returned with a large malodorous mass protruQing through the cervix <;>fan enlarged uterus. The 550 gram uterine specimen was 13 x 13 x 6 em. The myometrium was 4 em thick. A 8 x 6 em polypoid, pedunculated mass protruded through the cervix. The cut surface of the mass was partially hemorrhagic, surrounded by light tan soft tissue. (Contributed by David Seligson, M.D.) CASE #2- ACC. 24934 A 70-year-old female presented with vaginal bleeding of recent onset. A total abdominal hysterectomy and bilaterl!] salpingo-oophorectomx were performed. The 8 x 9 x 4 em uterus was symmetrically enlarged. The ·endometrial cavity was dilated by a 4.5 x 3.0 x4.0 em polypoid mass composed of loculated, somewhat mucoid tissue. Sections through the broad stalk revealed only superficial attachment to the myometrium, without obvious invasion. -
Ovarian Tumors in Children and Adolescents Linah Al-Alem University of Kentucky, [email protected]
University of Kentucky UKnowledge Pediatrics Faculty Publications Pediatrics 2010 Ovarian Tumors in Children and Adolescents Linah Al-Alem University of Kentucky, [email protected] Amit M. Deokar University of Kentucky Rebecca Timme University of Kentucky Hatim A. Omar University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/pediatrics_facpub Part of the Obstetrics and Gynecology Commons, and the Pediatrics Commons Repository Citation Al-Alem, Linah; Deokar, Amit M.; Timme, Rebecca; and Omar, Hatim A., "Ovarian Tumors in Children and Adolescents" (2010). Pediatrics Faculty Publications. 258. https://uknowledge.uky.edu/pediatrics_facpub/258 This Book Chapter is brought to you for free and open access by the Pediatrics at UKnowledge. It has been accepted for inclusion in Pediatrics Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Ovarian Tumors in Children and Adolescents Notes/Citation Information Published in Pediatric and Adolescent Sexuality and Gynecology: Principles for the Primary Care Clinician. Hatim A. Omar, Donald E. Greydanus, Artemis K. Tsitsika, Dilip R. Patel, & Joav Merrick, (Eds.). p. 597-627. © 2010 Nova Science Publishers, Inc. The opc yright holder has granted the permission for posting the book chapter here. This book chapter is available at UKnowledge: https://uknowledge.uky.edu/pediatrics_facpub/258 In: Pediatric and Adolescent Sexuality... ISBN: 978-1-60876-735-9 Ed: H. A. Omar et al. © 2010 Nova Science Publishers, Inc. Chapter 11 OVARIAN TUMORS IN CHILDREN AND ADOLESCENTS Linah Al-Alem, MSc, Amit M. -
Ovarian Cysts
Midlands Family Medicine 611 West Francis St. Suite 100 North Platte, NE 69101 Phone: (308) 534-2532 Fax: (308) 534-6615 Education Ovarian Cysts What are ovarian cysts? Ovarian cysts are fluid-filled sacs in or on an ovary. The two ovaries are part of the female reproductive system. They produce eggs and the female hormones estrogen and progesterone. How do they occur? Ovarian cysts are common and occur in two types: functional and abnormal. Functional cysts are quite normal. They may develop as a result of the normal functions of an ovary. The most common types of functional cysts are follicular and corpus luteum cysts: A follicular cyst forms when the follicle of an ovary gets bigger and fills with fluid as it produces an egg. A corpus luteum cyst occurs after an egg has been released from the follicle. If pregnancy does not occur, the corpus luteum usually disintegrates. However, occasionally it swells with fluid or blood and remains on the surface of the ovary as a cyst. Functional cysts should not occur after menopause. Abnormal cysts result from abnormal cell growth. Sometimes abnormal cysts are caused by cancer, but 95% of cysts are not cancerous. The most common abnormal cysts are dermoid cysts. These cysts are similar to skin tissue on the outside and are filled with fatty material and sometimes bits of bone, hair, nerve tissue, and cartilage. You have a higher risk for getting an ovarian cyst if: You have pelvic inflammatory disease (PID). You have endometriosis. You have bulimia. You are taking a drug for epilepsy called valproate. -
Benin Tumors of the Uterus and the Ovary
Benign tumors of women’s reproductive system PLAN OF LECTURE 1. Benign tumors of the uterus • Etiopathogenesis • Classification • Clinical symptoms • Diagnostics • Management 2. Benign ovarian tumors • Etiopathogenesis • Classification • Clinical symptoms • Diagnostics • Management Leiomyoma smooth muscule + fibrous connective tissue Frequency of uterine myoma makes 15-25% among women after 35-40 years Etiopathogenesis myoma - mesenchymal tumor (region of active growth formation around the vessels growing of tumor) + hyperoestrogenism Myomas are rarely found before puberty, and after menopause. The association of fibroids in women with hyperoestrogenism is evidenced by endometrial hyperplasia, abnormal uterine bleeding and endometrial carcinoma. Myomas increase in size: during pregnancy, with oral contraceptives, after delivery. Accoding to Location of uterus myomas Hysteromyoma classification: • А. By the node localization: 1. subserous – growth in the direction of the perimetrium; 2. intramural (interstitial) – growth into the thickness of the uterine wall; 3. submucous – node growth into the uterine cavity; 4. atypical – retrocervical, retroperitoneal, antecervical, subperitoneal, perecervical, intraligamentous. • В. By the node size (small, medium, and large) • C. By the growth form • (false – conditioned by blood supply disturbance and edema, and true – caused by the processes of smooth muscle cells proliferation). • D. By the speeding of the growth (fast and slowly) The symptoms of uterine fibroids Fibroids can also cause a number -
Histogenesis of Ovarian Malignant Mixed Mesodermal Tumours J Clin Pathol: First Published As 10.1136/Jcp.43.4.287 on 1 April 1990
J Clin Pathol 1990;43:287-290 287 Histogenesis of ovarian malignant mixed mesodermal tumours J Clin Pathol: first published as 10.1136/jcp.43.4.287 on 1 April 1990. Downloaded from T J Clarke Abstract embedded tumour tissue were cut at 4 im and The histogenesis of ovarian malignant stained with haematoxylin and eosin, periodic mixed mesodermal tumours, which acid Schiff (PAS) before and after diastase includes the concept of metaplastic car- treatment, Caldwell and Rannie's reticulin cinoma, is controversial. Four such stain, and phosphotungstic acid haematoxylin tumours were examined for evidence of (PTAH). Sequential sections were stained by metaplastic transition from carcinoma to the indirect immunoperoxidase technique sarcoma using morphology and reticulin using monoclonal antibodies directed against stains. Consecutive sections were stained cytokeratin (PKK1 which reacts with low immunohistochemically using cyto- molecular weight cytokeratins of44, 46, 52 and keratin and vimentin to determine 54 kilodaltons), vimentin, a-l-antitrypsin and whether cells at the interface between myoglobin. Appropriate positive and negative carcinoma and sarcoma expressed both controls, with omission of specific antisera in cytokeratin and vimentin. There was no the latter, were performed. Haematoxylin and evidence ofmorphological, architectural, eosin stained sections were examined for or immunohistochemical transitions secondary fluorescence using a Leitz Dialux from carcinoma to sarcoma in the four 20ES microscope and mercury vapour light tumours studied. This suggests that source epifluorescence. ovarian malignant mixed mesodermal Four patients, aged 68, 71, 72 and 73 presen- tumours are not metaplastic carcinomas ted with abdominal distension and discomfort but are composed of histogenetically dif- and were found to have an ovarian malignant ferent elements.